“alaska-permanent-fund” Archives

in
Entry Author Date Location
Indigo Adds $250M as It Expands Reach Into Agricultural Supply Chain 09/18/18 Boston
IPO to Fuel Denali’s Drugs for Alzheimer’s, Other Brain Diseases 11/13/17 San Francisco
Indigo Harvests $156M to Boost Agtech R&D, Harness Crop Microbes 09/26/17 Boston
Indigo’s Microbial Tech for Crops Lands $100M to Fight Plant Stresses 07/21/16 Boston
Indigo Garners $100,000,000 Series C Financing Round 07/21/16 Boston
After Three Deaths, FDA Halts Juno’s Leading CAR-T Trial 07/07/16 Seattle
Ex-Biogen Exec’s New Startup Gets $61M More For Exosome Drugs 01/26/16 Boston
Codiak BioSciences Receives $61,000,000 Series B Financing Round 01/26/16 Boston
East Coast Biotech Roundup: Pfizergan, Zafgen, Codiak, Boston Pharma 11/23/15 Boston
Codiak BioSciences Obtains $80,000,000 Series A Financing Round 11/18/15 San Francisco
Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M 11/17/15 Boston
Larry Corey, Cofounder of 2014 Top Biotech Juno: “It’s No Outlier” 01/05/15 Seattle
Juno Just Raised A Ton of Cash. Here Comes the Spending Part. 12/19/14 Seattle
Juno, Less Than a Year Old, Lines up IPO to Fund Cancer Work 11/17/14 Seattle
With $310M and Public Investors Aboard, Is a Juno IPO Next? 08/05/14 Seattle
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
Juno Therapeutics Receives $120,000,000 Series A Financing Round 12/05/13 Seattle
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
Page 1 of 1